axicabtagene ciloleucel,Tafasitamab
gilead,morphosys,incyte
['axi-cel', 'dlbcl', 'lymsm']
congress #eha2023 | melina sophie kurte presents a health economic evaluation for transplant-ineligible r/r #dlbcl pts in germany. rgemox, tafa-l and axi-cel were shown to be cost-effective treatment options.
#lymsm #medicalcongress 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm